Noscaflex Expectorans (Noscapine Hydrochloride, Guaifenesin)

Noscapine hydrochloride acts on the central cough centre, likely through sigma‑receptor modulation, which dampens the cough reflex and reduces the urge to cough without causing significant sedation.

The appropriate dose of Noscaflex Expectorans is determined by a qualified prescriber based on the patient’s age, weight, and clinical condition. Patients should follow the healthcare professional’s instructions and the product label.

Safety data for noscapine hydrochloride and guaifenesin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this product.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike single‑ingredient cough suppressants, Noscaflex Expectorans combines an antitussive (noscapine) with an expectorant (guaifenesin), offering both cough reduction and mucus clearance, which can be advantageous for patients with productive coughs.

Store the product below 25 °C in its original container, protecting it from moisture and direct sunlight. Keep it out of reach of children and do not use after the expiration date.

Noscaflex Expectorans is taken orally, usually with a full glass of water. It can be taken with or without food, unless the prescribing information advises otherwise.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and respiratory depression. Patients should seek immediate medical attention if they experience swelling, rash, difficulty breathing, or any unexpected severe symptoms.

Individuals with known hypersensitivity to noscapine, guaifenesin, or any excipients in the formulation should avoid this product. It should also be used with caution in patients taking other central cough suppressants or those with significant liver or kidney disease, after consulting a healthcare professional.